Projected Income Statement: Induct

Forecast Balance Sheet: Induct

Fiscal Period: December 2025 2026 2027 2028
Net Debt 1 - -3.6 4.7 8.6
Change - - 230.56% 82.98%
Announcement Date 2/12/26 - - -
1NOK in Million
Estimates

Cash Flow Forecast: Induct

Fiscal Period: December 2026 2027 2028
CAPEX 1 9 6 6
Change - -33.33% 0%
Free Cash Flow (FCF) 1 -4 -4 -1
Change - 0% 75%
Announcement Date - - -
1NOK in Million
Estimates

Forecast Financial Ratios: Induct

Fiscal Period: December 2025 2026 2027 2028

Profitability

    
EBITDA Margin (%) - 25.17% 40% 52.03%
EBIT Margin (%) - -62.24% -36.36% 0.41%
EBT Margin (%) - -69.23% -43.64% -5.69%
Net margin (%) -43.05% -69.23% -43.64% -6.1%
FCF margin (%) - -27.97% -24.24% -4.07%
FCF / Net Income (%) - 40.4% 55.56% 66.67%

Profitability

    
ROA - - - -
ROE - -25.2% -18.8% -4.3%

Financial Health

    
Leverage (Debt/EBITDA) - - 0.71x 0.67x
Debt / Free cash flow - - -1.18x -8.6x

Capital Intensity

    
CAPEX / Current Assets (%) - 62.94% 36.36% 24.39%
CAPEX / EBITDA (%) - 250% 90.91% 46.88%
CAPEX / FCF (%) - -225% -150% -600%

Items per share

    
Cash flow per share 1 - - - -
Change - - - -
Dividend per Share 1 - - - -
Change - - - -
Book Value Per Share 1 - - - -
Change - - - -
EPS 1 - -0.25 -0.15 -0.03
Change - - 40% 80%
Nbr of stocks (in thousands) - 31,309 31,309 31,309
Announcement Date - - - -
1NOK
Estimates
2026 *2027 *
P/E -2.51x -4.19x
PBR - -
EV / Sales 1.12x 1.48x
Yield - -

EPS & Dividend



Y-o-Y evolution of P/E

 
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.6280NOK
Average target price
1.000NOK
Spread / Average Target
+59.24%

Annual profits - Rate of surprise